Can erythropoietin be used to prevent brain damage in cerebral malaria?
Erythropoietin (Epo) modulates the survival of developing erythroid cells and the production of new erythrocytes in the bone marrow and is a key molecule in the adaptation to hypoxia and anaemia. Epo receptors have been found to be widely expressed on non-haematopoietic cells, and Epo has been shown...
Asıl Yazarlar: | Casals-Pascual, C, Idro, R, Picot, S, Roberts, D, Newton, C |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2009
|
Benzer Materyaller
-
Erythropoietin and neuro-protection in African children with cerebral malaria
Yazar:: Idro, R, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria.
Yazar:: Casals-Pascual, C, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome.
Yazar:: Idro, R, ve diğerleri
Baskı/Yayın Bilgisi: (2010) -
Pathogenesis, clinical features, and neurological outcome of cerebral malaria.
Yazar:: Idro, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005) -
A better biomarker for cerebral malaria: in the eye of the beheld?*.
Yazar:: Ackerman, H, ve diğerleri
Baskı/Yayın Bilgisi: (2012)